AU2001234171A1 - Parkin protein as ubiquitin ligase - Google Patents

Parkin protein as ubiquitin ligase

Info

Publication number
AU2001234171A1
AU2001234171A1 AU2001234171A AU3417101A AU2001234171A1 AU 2001234171 A1 AU2001234171 A1 AU 2001234171A1 AU 2001234171 A AU2001234171 A AU 2001234171A AU 3417101 A AU3417101 A AU 3417101A AU 2001234171 A1 AU2001234171 A1 AU 2001234171A1
Authority
AU
Australia
Prior art keywords
ubiquitin ligase
parkin protein
parkin
protein
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234171A
Other languages
English (en)
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2001234171A1 publication Critical patent/AU2001234171A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Noodles (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
AU2001234171A 2000-02-24 2001-02-26 Parkin protein as ubiquitin ligase Abandoned AU2001234171A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-47801 2000-02-24
JP2000047801 2000-02-24
PCT/JP2001/001399 WO2001062957A1 (fr) 2000-02-24 2001-02-26 Proteine parkine utilisee comme ubiquitine ligase

Publications (1)

Publication Number Publication Date
AU2001234171A1 true AU2001234171A1 (en) 2001-09-03

Family

ID=18569991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234171A Abandoned AU2001234171A1 (en) 2000-02-24 2001-02-26 Parkin protein as ubiquitin ligase

Country Status (10)

Country Link
US (1) US20050042607A1 (da)
EP (1) EP1262557B1 (da)
AT (1) ATE343001T1 (da)
AU (1) AU2001234171A1 (da)
CA (1) CA2398703A1 (da)
DE (1) DE60123934T2 (da)
DK (1) DK1262557T3 (da)
ES (1) ES2272444T3 (da)
MX (1) MXPA02008256A (da)
WO (1) WO2001062957A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1969367B1 (en) * 2005-12-12 2011-08-10 Elan Pharmaceuticals Inc. Assay for parkinson's disease therapeutics
US8017348B1 (en) * 2005-12-12 2011-09-13 Elan Pharma International Limited Assay for Parkinson's Disease therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315645T1 (de) * 1998-02-09 2006-02-15 Boehringer Ingelheim Int Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
GB9826276D0 (en) * 1998-12-01 1999-01-20 Univ Leeds Therapeutic agents for use in degenerative disorders
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein

Also Published As

Publication number Publication date
EP1262557B1 (en) 2006-10-18
US20050042607A1 (en) 2005-02-24
ATE343001T1 (de) 2006-11-15
CA2398703A1 (en) 2001-08-30
EP1262557A1 (en) 2002-12-04
WO2001062957A1 (fr) 2001-08-30
ES2272444T3 (es) 2007-05-01
DE60123934T2 (de) 2007-10-18
DK1262557T3 (da) 2006-11-13
EP1262557A4 (en) 2003-05-02
DE60123934D1 (de) 2006-11-30
MXPA02008256A (es) 2003-01-28

Similar Documents

Publication Publication Date Title
AU2001262602A1 (en) Short messaging using information beacons
WO2003012119A3 (en) Nucleic acid amplification method
EP1300932A3 (en) Linear motor, stage apparatus, and exposure apparatus
AU2003246268A1 (en) Image combination device, image combination method, image combination program, and recording medium containing the image combination program
AU3849199A (en) Aberration measuring instrument and measuring method, projection exposure apparatus provided with the instrument and device-manufacturing method using the measuring method, and exposure method
AU2001237644A1 (en) Optical code generation and detection
AU7552498A (en) Optical device, method of cleaning the same, projection aligner, and method of producing the same
AU2000243170A1 (en) Information providing device, and information providing method
AU2003291770A1 (en) Imaging device, focusing method and program
AU2001232285A1 (en) Laser condensing apparatus and laser machining apparatus
WO2002102586A3 (en) Cellulose-polymer composites and methods for manufacturing same
AU2002349504A1 (en) Code reading apparatus
AU2003221102A1 (en) Projection optical system, exposure system and exposure method
AU2002214269A1 (en) Optical device, exposure device and device manufacturing method
EP1248160B8 (en) Developing device, charging method used therefor, and printing apparatus having the developing device
AU5906699A (en) (neisseria spp.) polypeptide, nucleic acid sequence and uses thereof
EP1138514A3 (en) Recording material for ink-jet recording
AU2001242389A1 (en) Test system based on microcapillaries
AU2001234171A1 (en) Parkin protein as ubiquitin ligase
AU2001228878A1 (en) Pupil center determination recorder
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
AU2001285905A1 (en) 6,7-dihydro-pyrrolo(3,4-b)pyridin-5-ones with an anticonvulsive action and methods for producing the same
AU2001245028A1 (en) System and method for providing information based on user histories
AU2001252608A1 (en) Novel (R)-2-hydroxy-3-phenylpropionate (D-phenyllactate) dehydrogenase and gene encoding the same